Cargando…
Atypical periprosthetic femoral fracture associated with long-term bisphosphonate therapy
BACKGROUND: Atypical femoral fracture is one of the many complications after the long-term use of bisphosphonates. The American Society for Bone and Mineral Research has officially excluded periprosthetic femoral fractures (PFFs) from the definition of atypical femoral fractures (AFFs). Several case...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493328/ https://www.ncbi.nlm.nih.gov/pubmed/32933566 http://dx.doi.org/10.1186/s13018-020-01941-x |
_version_ | 1783582545325064192 |
---|---|
author | Dózsai, Dávid Ecseri, Tamás Csonka, István Gárgyán, István Doró, Péter Csonka, Ákos |
author_facet | Dózsai, Dávid Ecseri, Tamás Csonka, István Gárgyán, István Doró, Péter Csonka, Ákos |
author_sort | Dózsai, Dávid |
collection | PubMed |
description | BACKGROUND: Atypical femoral fracture is one of the many complications after the long-term use of bisphosphonates. The American Society for Bone and Mineral Research has officially excluded periprosthetic femoral fractures (PFFs) from the definition of atypical femoral fractures (AFFs). Several case reports found that PFFs can occur with characteristics similar to those of AFFs. The purpose of our study was to evaluate the proportion of atypical fractures among Vancouver type B1 fractures, and to determine the association between the long-term use of bisphosphonates and the occurrence of atypical periprosthetic femoral fractures (APFFs). METHODS: In this retrospective study, we reviewed 41 patients with Vancouver type B1 periprosthetic fractures between January 1, 2011 and December 31, 2018. We classified them into two groups, namely atypical and typical PFFs, based on the fracture morphology. We noted the proportion of atypical periprosthetic fractures among B1 fractures and identified risk factors. RESULTS: Among the 41 PFFs, 5 (13%) fractures were classified as atypical PFF based on the radiological characteristics. The longer duration of bisphosphonate use was probably the only independent risk factor that significantly increases the occurrence of APFF (p = 0.03, 0.08 (CI 0.008 – 0.16)). There were no significant differences in age, gender, body mass index, comorbidities, corticosteroid use, positioning of the femoral stem, the method of fixation (cemented or cementless) and time lapse from before the primary prosthesis implantation to the PFF in the development of atypical fracture type. CONCLUSIONS: There seems to be a correlation between the long-term intake of bisphosphonates and the atypical periprosthetic fracture. Atypical femoral fracture can also occur in the periprosthetic form. TRIAL REGISTRATION: Study number: 22/2019-SZTE, http://www.klinikaikutatas.hu/hu/kutatasetika/jovahagyott-vizsgalatok-koezerdeku-adatai/category/25-jovahagyott-vizsgalatok-kozerdeku-adatai-rkeb-2019.html?download=985:22-2019. |
format | Online Article Text |
id | pubmed-7493328 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-74933282020-09-16 Atypical periprosthetic femoral fracture associated with long-term bisphosphonate therapy Dózsai, Dávid Ecseri, Tamás Csonka, István Gárgyán, István Doró, Péter Csonka, Ákos J Orthop Surg Res Research Article BACKGROUND: Atypical femoral fracture is one of the many complications after the long-term use of bisphosphonates. The American Society for Bone and Mineral Research has officially excluded periprosthetic femoral fractures (PFFs) from the definition of atypical femoral fractures (AFFs). Several case reports found that PFFs can occur with characteristics similar to those of AFFs. The purpose of our study was to evaluate the proportion of atypical fractures among Vancouver type B1 fractures, and to determine the association between the long-term use of bisphosphonates and the occurrence of atypical periprosthetic femoral fractures (APFFs). METHODS: In this retrospective study, we reviewed 41 patients with Vancouver type B1 periprosthetic fractures between January 1, 2011 and December 31, 2018. We classified them into two groups, namely atypical and typical PFFs, based on the fracture morphology. We noted the proportion of atypical periprosthetic fractures among B1 fractures and identified risk factors. RESULTS: Among the 41 PFFs, 5 (13%) fractures were classified as atypical PFF based on the radiological characteristics. The longer duration of bisphosphonate use was probably the only independent risk factor that significantly increases the occurrence of APFF (p = 0.03, 0.08 (CI 0.008 – 0.16)). There were no significant differences in age, gender, body mass index, comorbidities, corticosteroid use, positioning of the femoral stem, the method of fixation (cemented or cementless) and time lapse from before the primary prosthesis implantation to the PFF in the development of atypical fracture type. CONCLUSIONS: There seems to be a correlation between the long-term intake of bisphosphonates and the atypical periprosthetic fracture. Atypical femoral fracture can also occur in the periprosthetic form. TRIAL REGISTRATION: Study number: 22/2019-SZTE, http://www.klinikaikutatas.hu/hu/kutatasetika/jovahagyott-vizsgalatok-koezerdeku-adatai/category/25-jovahagyott-vizsgalatok-kozerdeku-adatai-rkeb-2019.html?download=985:22-2019. BioMed Central 2020-09-15 /pmc/articles/PMC7493328/ /pubmed/32933566 http://dx.doi.org/10.1186/s13018-020-01941-x Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Dózsai, Dávid Ecseri, Tamás Csonka, István Gárgyán, István Doró, Péter Csonka, Ákos Atypical periprosthetic femoral fracture associated with long-term bisphosphonate therapy |
title | Atypical periprosthetic femoral fracture associated with long-term bisphosphonate therapy |
title_full | Atypical periprosthetic femoral fracture associated with long-term bisphosphonate therapy |
title_fullStr | Atypical periprosthetic femoral fracture associated with long-term bisphosphonate therapy |
title_full_unstemmed | Atypical periprosthetic femoral fracture associated with long-term bisphosphonate therapy |
title_short | Atypical periprosthetic femoral fracture associated with long-term bisphosphonate therapy |
title_sort | atypical periprosthetic femoral fracture associated with long-term bisphosphonate therapy |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493328/ https://www.ncbi.nlm.nih.gov/pubmed/32933566 http://dx.doi.org/10.1186/s13018-020-01941-x |
work_keys_str_mv | AT dozsaidavid atypicalperiprostheticfemoralfractureassociatedwithlongtermbisphosphonatetherapy AT ecseritamas atypicalperiprostheticfemoralfractureassociatedwithlongtermbisphosphonatetherapy AT csonkaistvan atypicalperiprostheticfemoralfractureassociatedwithlongtermbisphosphonatetherapy AT gargyanistvan atypicalperiprostheticfemoralfractureassociatedwithlongtermbisphosphonatetherapy AT doropeter atypicalperiprostheticfemoralfractureassociatedwithlongtermbisphosphonatetherapy AT csonkaakos atypicalperiprostheticfemoralfractureassociatedwithlongtermbisphosphonatetherapy |